These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8826444)

  • 1. An assay for X inactivation based on differential methylation at the fragile X locus, FMR1.
    Carrel L; Willard HF
    Am J Med Genet; 1996 Jul; 64(1):27-30. PubMed ID: 8826444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of the absence of FMR1 expression in full mutation chorionic villi.
    Willemsen R; Bontekoe CJ; Severijnen LA; Oostra BA
    Hum Genet; 2002 Jun; 110(6):601-5. PubMed ID: 12107447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene.
    Steyaert J; Borghgraef M; Legius E; Fryns JP
    Am J Med Genet; 1996 Aug; 64(2):274-7. PubMed ID: 8844064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
    Sharma D; Gupta M; Thelma BK
    Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene.
    Hansen RS; Gartler SM; Scott CR; Chen SH; Laird CD
    Hum Mol Genet; 1992 Nov; 1(8):571-8. PubMed ID: 1301165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X inactivation of the FMR1 fragile X mental retardation gene.
    Kirchgessner CU; Warren ST; Willard HF
    J Med Genet; 1995 Dec; 32(12):925-9. PubMed ID: 8825916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
    Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion in the FMR1 gene in a fragile-X male.
    Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
    Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X syndrome without CCG amplification has an FMR1 deletion.
    Gedeon AK; Baker E; Robinson H; Partington MW; Gross B; Manca A; Korn B; Poustka A; Yu S; Sutherland GR
    Nat Genet; 1992 Aug; 1(5):341-4. PubMed ID: 1302032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
    Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
    Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation and intergenerational FMR1 CGG-repeat stability in 100 unrelated three-generation families from the normal population.
    Patsalis PC; Sismani C; Stylianou S; Ioannou P; Joseph G; Manoli P; Holden JJ; Hettinger JA
    Am J Med Genet; 1999 May; 84(3):217-20. PubMed ID: 10331595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling methylation and IQ scores in fragile X females and mosaic males.
    Kolehmainen K; Karant Y
    Am J Med Genet; 1994 Jul; 51(4):328-38. PubMed ID: 7942995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methylation status of the FMR1 gene promotor in patients with Martin-Bell syndrome from Ukraine].
    Grishchenko NV; Maliarchuk SG; Ekshiian AIu; Bychkova AM; Livshits LA
    Tsitol Genet; 2002; 36(4):53-6. PubMed ID: 12379018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice.
    Lavedan C; Grabczyk E; Usdin K; Nussbaum RL
    Genomics; 1998 Jun; 50(2):229-40. PubMed ID: 9653650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of expansion of CGG repeats and X-inactivation with expression of fra(X)(q27.3) in heterozygotes.
    Mingroni-Netto RC; Fernandes JG; Vianna-Morgante AM
    Am J Med Genet; 1994 Jul; 51(4):443-6. PubMed ID: 7943014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X syndrome and deletions in FMR1: new case and review of the literature.
    Hammond LS; Macias MM; Tarleton JC; Shashidhar Pai G
    Am J Med Genet; 1997 Nov; 72(4):430-4. PubMed ID: 9375726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of FMR1 hypermethylation in somatic cell heterokaryons.
    Stoyanova V; Rossetti S; VAN Unen L; Oostra BA; Hoogeveen AT
    FASEB J; 2004 Dec; 18(15):1964-6. PubMed ID: 15377638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.